Position in RPRX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$31,819,556
+$14,286,858 QoQ
Shares Held
567,497
+55.3% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#11
of 236 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. RPRX ranks #6 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
This page
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
272,900 | $31,293,443 |
All Filings in RPRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,819,556 | 567,497 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $17,532,698 | 365,493 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $9,192,340 | 237,897 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $6,851,446 | 194,202 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,713,467 | 103,066 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $2,590,358 | 83,211 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,415,626 | 55,493 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,272,880 | 44,994 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,164,815 | 44,172 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,097,109 | 69,052 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $6,184,940 | 220,183 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $7,883,708 | 290,483 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $5,977,608 | 194,457 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $7,289,337 | 202,313 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $7,956,047 | 201,317 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $7,691,617 | 191,429 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $8,650,865 | 205,777 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $6,546,643 | 168,035 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $6,671,168 | 167,407 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $5,583,340 | 154,492 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $6,373,617 | 155,492 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $6,673,511 | 152,992 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $7,366,959 | 147,192 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $10,891,544 | 258,891 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $9,170,658 | 188,891 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||